Previous 10 | Next 10 |
FARMINGDALE, N.Y., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced today that it will report its fiscal 2021 second quarter financi...
FARMINGDALE, N.Y., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be participating in the 39 th Annual J.P....
Misonix ([[MSON]] +0.4%) has announced that the second largest U.S. Commercial payer will now cover TheraSkin, cellular and tissue-based treatment for all lower extremity dermal wounds, including venous leg ulcers and diabetic foot ulcers.The comp...
FARMINGDALE, N.Y., Dec. 18, 2020 (GLOBE NEWSWIRE) -- 2020) – Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that the second largest U.S. Commercial pay...
FARMINGDALE, N.Y., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that Chief Executive Officer, Stavros Vizirgianakis, along wit...
FARMINGDALE, N.Y., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be participating in the upcoming Craig-Hallum and...
Misonix, Inc. (MSON) Q1 2021 Results Conference Call November 05, 2020 04:30 PM ET Company Participants Norberto Aja - IR Stavros Vizirgianakis - CEO Joe Dwyer - CFO Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Ian Tolle - Canaccord Presentation Operator Good day, ever...
Image source: The Motley Fool. Misonix Inc (NASDAQ: MSON) Q1 2021 Earnings Call Nov 5, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: Misonix Inc (MSON) Q1 2021 Earnings Call Transcript
MISONIX (MSON): FQ1 GAAP EPS of -$0.29 beats by $0.01.Revenue of $12.62M (+59.5% Y/Y) misses by $4.53M.Press Release For further details see: MISONIX EPS beats by $0.01, misses on revenue
FARMINGDALE, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported unaudi...
News, Short Squeeze, Breakout and More Instantly...
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, and Misonix, Inc. (Nasdaq: MSON) (“Misonix”), a provider of...
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) and Misonix, Inc . (Nasdaq: MSON) (“Misonix”), today announced an election deadline of 5:00 p.m., New York City Time, on October 25, 2021 (the “Election Deadline...
FARMINGDALE, N.Y., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported unaud...